Generate a structured brief — facts, issues, held, reasoning, and significance — for this case in seconds. Or browse the verbatim judgment via the source links below.
(Appeal — Order for interim measures — Suspension of operation of a measure challenged before the General Court — Change in circumstances — Access to documents — Regulation (EC) No 1049/2001 — Documents held by the European Medicines Agency (EMA) submitted as part of an application for authorisation to place a medicinal product on the market — Decision to grant a third party access to the documents)
APPEAL under the second paragraph of Article 57 of the Statute of the Court of Justice of the European Union, brought on 19 July 2016,
European Medicines Agency (EMA), represented by S. Marino, A. Spina, A. Rusanov, T. Jabłoński and N. Rampal Olmedo, acting as Agents,
Pari Pharma GmbH, established in Starnberg (Germany), represented by M. Epping and W. Rehmann, Rechtsanwälte,
Novartis Europharm Ltd, established in Camberley (United Kingdom), represented by C. Schoonderbeek, avocate,
Auto-extracted from BAILII. Full structured brief in progress — the source links below give you the verbatim judgment in the meantime.
Multiple official and mirror sources — pick whichever loads cleanly on your network.
Common Room
0 comments · About the Common Room →
No comments yet — start the discussion.
Voted-best comments help future students and feed Caselaw's AI study tools.